P3 Health Partners Inc.
PIII
$0.1851
-$0.0009-0.48%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 25.38% | 23.31% | 25.49% | 20.67% | 20.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.38% | 23.31% | 25.49% | 20.67% | 20.60% |
| Cost of Revenue | 33.50% | 25.39% | 23.61% | 16.79% | 14.88% |
| Gross Profit | -196.89% | -66.22% | 1,991.08% | 508.04% | 431.82% |
| SG&A Expenses | -20.03% | -22.78% | -29.02% | -22.65% | -23.46% |
| Depreciation & Amortization | -0.58% | -0.63% | -0.46% | -0.70% | 19.58% |
| Other Operating Expenses | 216.08% | -230.31% | -237.10% | -10.84% | -146.31% |
| Total Operating Expenses | 27.67% | 17.57% | 14.77% | 10.72% | 6.62% |
| Operating Income | -42.95% | 14.62% | 32.84% | 31.72% | 39.84% |
| Income Before Tax | 61.49% | 73.41% | 88.45% | 88.22% | 43.62% |
| Income Tax Expenses | -56.92% | 119.47% | 108.04% | 44.74% | -- |
| Earnings from Continuing Operations | 61.47% | 72.73% | 88.18% | 88.06% | 43.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -71.79% | -79.17% | -90.94% | -90.04% | -41.92% |
| Net Income | 18.71% | 44.07% | 74.97% | 78.61% | 48.73% |
| EBIT | -42.95% | 14.62% | 32.84% | 31.72% | 39.84% |
| EBITDA | -85.19% | 25.15% | 50.96% | 48.79% | 59.42% |
| EPS Basic | 71.99% | 79.50% | 90.93% | 90.00% | -11.81% |
| Normalized Basic EPS | -100.69% | -99.73% | -99.86% | -98.96% | -43.09% |
| EPS Diluted | 54.65% | 63.89% | 85.03% | 84.17% | -11.06% |
| Normalized Diluted EPS | -100.68% | -99.77% | -99.74% | -97.83% | 265.03% |
| Average Basic Shares Outstanding | 74.75% | 108.86% | 174.05% | 127.57% | 83.28% |
| Average Diluted Shares Outstanding | 7.28% | 58.64% | 15.14% | 1.54% | -11.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
